Patents by Inventor Gerard Bulteau

Gerard Bulteau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 2,3-alkylene di (oxy) benzamides and derivatives
    Patent number: 4323503
    Abstract: Novel substituted 2,3-alkylene bis (oxy) benzamides and derivatives thereof are disclosed. Also disclosed is a method for producing said compounds. The compounds have anxiolytic, psychostimulant, disinhibiting and thymoanaleptic properties useful therapeutically in the psychofunctional field, particularly in gastro-enterology, cardiology, urology, rheumatology and gynaecology.
    Type: Grant
    Filed: June 12, 1979
    Date of Patent: April 6, 1982
    Assignee: Societe d'Etudes Scientifiques et Industrielles de L'ile-de-France
    Inventors: Michel Thominet, Gerard Bulteau, Jacques Acher, Claude Collignon
  • Substituted 2,3-alkylene bis (oxy)-4,5 (or 5,6) azimido benzamides and derivatives thereof
    Patent number: 4306072
    Abstract: Novel substituted 2,3-alkylene bis (oxy) benzamide azimido compounds and derivatives thereof are disclosed as for example N-(1-allyl-2-pyrrolidylmethyl)-7,8-azimido-1,4-benzodioxane-5-carboxamide and N-(1-allyl-2-pyrrolidylmethyl)-6,7-azimido-1,4-benzodioxane-5-carboxamide. The compounds have anxiolytic, psychostimulant, disinhibiting and thymoanaleptic properties useful therapeutically in the psychofunctional field, particularly in gastro-enterology, cardiology, urology, rheumatology and gynaecology.
    Type: Grant
    Filed: July 26, 1979
    Date of Patent: December 15, 1981
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile
    Inventors: Michel Thominet, Gerard Bulteau, Jacques Acher, Claude Collignon
  • Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
    Patent number: 4268512
    Abstract: Novel substituted 2,3-alkylene bis (oxy) benzamides and derivatives thereof are disclosed. Also disclosed is a method for producing said compounds. The compounds have anxiolytic, psychostimulant, disinhibiting and thymoanaleptic properties useful therapeutically in the psychofunctional field, particularly in gastro-enterology, cardiology, urology, rheumatology and gynaecology.
    Type: Grant
    Filed: February 23, 1979
    Date of Patent: May 19, 1981
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Michel Thominet, Gerard Bulteau, Jacques Acher, Claude Collignon
  • Substituted 2,3-alkylene bis(oxy) benzamides and derivatives to treat psychofunctional disorders
    Patent number: 4248885
    Abstract: Novel substituted 2,3-alkylene bis (oxy) benzamides and derivatives thereof are disclosed. Also disclosed is a method for producing said compounds. The compounds have anxiolytic, psychostimulant, disinhibiting and thymoanaleptic properties useful therapeutically in the psychofunctional field, particularly in gastro-enterology, cardiology, urology, rheumatology and gynaecology.
    Type: Grant
    Filed: February 23, 1979
    Date of Patent: February 3, 1981
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Michel Thominet, Gerard Bulteau, Jacques Acher, Claude Collignon
  • Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
    Patent number: 4186135
    Abstract: Novel substituted 2,3-alkylene bis (oxy) benzamides and derivatives thereof are disclosed. Also disclosed is a method for producing said compounds. The compounds have anxiolytic, psychostimulant, disinhibiting and thymoanaleptic properties useful therapeutically in the psychofunctional field, particularly in gastro-enterology, cardiology, urology, rheumatology and gynaecology.
    Type: Grant
    Filed: August 2, 1977
    Date of Patent: January 29, 1980
    Assignee: Societe D'Etudes Scientifiques et Industrielles de L'ile-de-France
    Inventors: Michel Thominet, Gerard Bulteau, Jacques Acher, Claude Collignon
  • Process for producing enamines
    Patent number: 4166060
    Abstract: Enamines which are employed to obtain benzamides effective in the treatment of emesis are produced by efficient processes.
    Type: Grant
    Filed: December 21, 1977
    Date of Patent: August 28, 1979
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Gerard Bulteau, Jacques Acher, Jean-Claude Monier
  • N-(1'-ethyl-2'-oxo-5'-pyrrolidinylmethyl) benzamide compounds and derivatives, method of preparation and pharmaceutical preparations
    Patent number: 4161532
    Abstract: Novel substituted N-(1'-ethyl-2'-oxo-5'-pyrrolidinylmethyl) benzamide comnds and derivatives thereof are disclosed. The compounds have psychotropic properties and may be used in pharmaceutical compositions as behavior modifiers.
    Type: Grant
    Filed: April 14, 1978
    Date of Patent: July 17, 1979
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile de France
    Inventors: Gerard Bulteau, Jacques Acher, Jean C. Monier
  • Enamines, their derivatives and processes of production
    Patent number: 4077976
    Abstract: The enamines of this invention are useful in the preparation of certain benzamides employed in the treatment of emesis in mammals.
    Type: Grant
    Filed: June 11, 1976
    Date of Patent: March 7, 1978
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Gerard Bulteau, Jacques Acher, Jean-Claude Monier
  • N-(1'-Allypyrrolidinyl 2'-methyl) 2-methoxy 4,5-azimido benzamide and its pharmaceutically acceptable salts
    Patent number: 4039672
    Abstract: The azimido benzamide of this invention and its pharmaceutically acceptable salts have an unusually and unexpectedly high therapeutic index and low toxicity in the treatment of emesis in mammals. Pharmacological testing demonstrated the superior efficacy of the compound of this invention over known, similar compounds.
    Type: Grant
    Filed: March 3, 1975
    Date of Patent: August 2, 1977
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Gerard Bulteau, Jacques Acher, Claude Collignon, Jean-Claude Monier
  • N-(1-benzyl pyrrolidinyl 2-alkyl) substituted benzamides and derivatives thereof
    Patent number: 4029673
    Abstract: The benzamides of this invention and their pharmaceutically acceptable salts are particularly effective in the treatment of emesis and ulcers in mammals. Their low level of toxicity is compatible with use in human therapy, without undesirable side effects.
    Type: Grant
    Filed: March 5, 1975
    Date of Patent: June 14, 1977
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Gerard Bulteau, Jacques Acher, Jean-Claude Monier
  • Processes of producing 2,5-disubstituted benzamides
    Patent number: 3975434
    Abstract: 2,5-Disubstituted benzamides are produced by an efficient, effective and economical method by the utilization of 4-methyl 2-chloro 1-3-2-dioxophosphorinane as a catalyst.
    Type: Grant
    Filed: September 23, 1974
    Date of Patent: August 17, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Gerard Bulteau, Jacques Acher, Jean-Claude Monier